Characterizing Markets for Biopharmaceutical Innovations: Do Biologics Differ from Small Molecules?Mark R. Trusheim, Murray L. Aitken, Ernst R. Berndt
Chapter in NBER book Frontiers in Health Policy Research, volume 13 (2010), David Cutler, Alan Garber, Dana Goldman, and William Vogt, organizers This chapter is not currently available on-line.
|

National Bureau of Economic Research, 1050 Massachusetts Ave.,
Cambridge, MA 02138; 617-868-3900; email: info@nber.org
Contact Us
Contact Us








